Title:
LACTOBACILLUS RHAMNOSUS LM1019 STRAIN, AND COMPOSITION FOR PREVENTING AND TREATING OBESITY OR DIABETES INCLUDING SAME
Document Type and Number:
WIPO Patent Application WO/2019/050287
Kind Code:
A1
Abstract:
The present invention relates to a Lactobacillus rhamnosus LM1019 strain (accession number: KCCM12308P), and a composition for preventing and treating obesity or diabetes including same. Specifically, the Lactobacillus rhamnosus LM1019 strain according to the present invention reduces fat cells, neutral lipids, subcutaneous fat, and cholesterol, thus having an obesity prevention and treatment effect, and also reduces the blood concentrations of glucose and insulin, thereby suppressing insulin resistance and thus having a diabetes prevention and treatment effect.
Inventors:
PARK HAN SOO (KR)
Application Number:
PCT/KR2018/010400
Publication Date:
March 14, 2019
Filing Date:
September 06, 2018
Export Citation:
Assignee:
GENOMEANDCOMPANY (KR)
LACTOMASON CO LTD (KR)
LACTOMASON CO LTD (KR)
International Classes:
C12N1/20; A23C9/12; A23K10/16; A23L29/00; A23L33/135; A61K35/747; C12R1/225
Domestic Patent References:
| WO2015172191A1 | 2015-11-19 |
Foreign References:
| US20150283186A1 | 2015-10-08 | |||
| JP2016520305A | 2016-07-14 | |||
| KR101611837B1 | 2016-04-14 | |||
| KR101864347B1 | 2018-06-05 |
Other References:
LEE, H.-Y.: "Human originated bacteria, Lactobacillus rhamnosus PL 60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1761, no. 7, 2006, pages 736 - 744, XP028040083
Attorney, Agent or Firm:
CHOI, Eun Sun (KR)
Download PDF:
Previous Patent: EXTERIOR MATERIAL OF HOME APPLIANCE, HOME APPLIANCE INCLUDING THE EXTERIOR MATERIAL, AND MANUFACTURI...
Next Patent: PELLICLE FRAME
Next Patent: PELLICLE FRAME